Skip to main
MGNX
MGNX logo

MacroGenics (MGNX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy MacroGenics (MGNX) Stock

About MacroGenics (MGNX)

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. H...read more
Market cap$95.9M
Today's volume955.19K
Revenue (TTM)$154.05M
Avg. daily volume1.15M
EBITDA (TTM)-$91.98M
Open$1.50
Price / earnings ratio-1.71x
Today's range$1.48 - $1.6
Debt / equity47.35x
52 week range$0.99 - $5.77
5 year debt / equity17.26x
Beta (LTM)1.57x
Interest coverage-99.17x
Dividend & yield$0.00 (0.00%)
Current ratio3.28x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

MacroGenics Stock Rating

What analysts recommend for MGNX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 33%
Buy 46%
Hold 17%
Sell 4%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for MGNX stock is $95.9M

The current P/E ratio for MGNX stock is -1.71

The 52-week high for MGNX stock is $5.77. The current MGNX stock price $undefined is 100.00% below its 52-week high

The 52-week low for MGNX stock is $0.99. The current MGNX stock price $undefined has increased 100.00% from its 52-week low

No, the MGNX stock does not pay dividends to its shareholders

The target price for MGNX stock is $22.08 based on the average of what a group of analyst think MGNX stock could be worth at a future date. This is not a prediction by Public.com

How to buy MGNX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MGNX stock

    Navigate to the Explore page. Then, type MGNX into the search bar. When you see MGNX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MGNX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

MacroGenics Stock Earnings

The value each MGNX share was expected to gain vs. the value that each MGNX share actually gained.

MacroGenics (MGNX) reported Q1 2025 earnings per share (EPS) of -$0.65, beating estimates of -$0.69 by 5.80%. In the same quarter last year, MacroGenics's earnings per share (EPS) was -$0.84. MacroGenics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.

Buy MacroGenics (MGNX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.